Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > LIAN LianBio > Detailed Quotes

LIAN LianBio

Watchlist
2.200
-0.090-3.93%
Close  02/03 16:00 ET
2.100
-0.100-4.55%
Post Mkt Price 02/03 17:34 ET
High
2.320
Open
2.200
Turnover
589.39K
Low
2.050
Pre Close
2.290
Volume
268.25K
Market Cap
238.38M
P/E(TTM)
Loss
52wk High
6.240
Shares
108.35M
P/E(Static)
Loss
52wk Low
1.070
Float Cap
35.43M
Bid/Ask %
95.12%
Historical High
16.370
Shs Float
16.10M
Volume Ratio
1.78
Historical Low
1.070
Dividend TTM
--
Div Yield TTM
--
P/B
0.87
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.67%
Amplitude
11.79%
Avg Price
2.197
Lot Size
1
Float Cap
35.43M
Bid/Ask %
95.12%
Historical High
16.370
Shs Float
16.10M
Volume Ratio
1.78
Historical Low
1.070
Dividend TTM
--
P/B
0.87
Dividend LFY
--
Turnover Ratio
1.67%
Amplitude
11.79%
Avg Price
2.197
Lot Size
1
Price Forecast

News

Comment

Company Overview More
LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.
CEO: Dr. Yizhe Wang, PhD
Market: NASDAQ
Listing Date: 11/01/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist